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Intermittent hypoxia, defined as alternating bouts of breathing hypoxic and 
normoxic air, has the potential to improve oxygen-carrying capacity through an 
erythropoietin-mediated increase in hemoglobin mass. The purpose of this study was to 
determine the effect of a single exposure of intermittent normobaric hypoxia on 
erythropoietin levels and hemoglobin mass in young healthy individuals. Nineteen healthy 
individuals (10 women and 9 men, age: 24 ± 4 years, height: 174 ± 11 cm, weight: 72.2 ± 
12.2 kg) participated in the study. Participants were randomly assigned to an intermittent 
hypoxia group (Hyp, n = 10) or a placebo intermittent normoxia group (Norm, n = 9). 
Intermittent hypoxia consisted of five 4-minute hypoxic cycles at a targeted arterial oxygen 
saturation of 90% interspersed with 4-minute normoxic cycles. Air was made hypoxic by 
titrating nitrogen to a breathing circuit connected to a tank of compressed air. Nitrogen was 
not added to the breathing circuit in the intermittent normoxia condition. Pulmonary gas 
exchange, arterial oxygen saturation, and hemodynamics, using finger plethysmography, 
were continuously assessed during the intervention. Erythropoietin levels were measured 
before and two hours following the completion of the protocol. Hemoglobin mass was 
assessed using the carbon monoxide rebreathing technique the day before and seven days 
after exposure to intermittent hypoxia or normoxia. As anticipated, the intermittent hypoxia 
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group had a lower arterial oxygen saturation than the intermittent normoxia group during 
the intervention (Hyp: 89 ± vs. Norm: 98 ± 1%, p < 0.01), which was equivalent to a lower 
fraction of inspired oxygen (Hyp: 0.119 ± 0.008, Norm: 0.209 ± 0.001, p < 0.01). 
Erythropoietin levels did not significantly increase following exposure to intermittent 
hypoxia (Hyp: 8.2 ± 4.5 to 9.0 ± 4.8, Norm: 8.9 ± 1.7 to 11.1 ± 2.1 mU/ml, p = 0.56). 
Hemoglobin mass did not change following exposure to intermittent hypoxia (Hyp: 10.6 ± 
1.4 to 10.2 ± 1.4, Norm: 9.7 ± 1.6 to 9.4 ± 1.5 g/kg, p = 0.48). Exposure to intermittent 
hypoxia did not affect mean arterial pressure (Hyp: 91 ± 6 to 90 ± 6, Norm: 93 ± 12 to 93 
± 12 mmHg, p = 0.84) or heart rate (Hyp: 68 ± 8 to 74 ± 9, Norm: 68 ± 8 to 68 ± 8 mmHg, 
p = 0.27). Respiratory rate, tidal volume, end-tidal CO2 and total minute ventilation were 
not affected by intermittent hypoxia. Thus, a 40-minute session of intermittent hypoxia was 
not sufficient to elicit a rise in erythropoietin levels or hemoglobin mass in young healthy 
individuals. A longer exposure to intermittent hypoxia at a lower arterial oxygen saturation 
may be necessary to trigger an erythropoietin-mediated increase in hemoglobin mass in 
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RELATIONSHIP BETWEEN HEMOGLOBIN MASS AND VO2MAX 
 
Maximal oxygen consumption (VO2max) represents a measure of 
cardiorespiratory fitness. According to the Fick equation, VO2 is the product of cardiac 
output and arterio-venous oxygen (a-vO2) difference:  
  
𝑉𝑂# 	= 𝐶𝑎𝑟𝑑𝑖𝑎𝑐	𝑂𝑢𝑡𝑝𝑢𝑡	 × (𝑎 − 𝑣𝑂#	𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒) 
and 
𝑎 − 𝑣𝑂#	𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 = 𝐶𝑎𝑂# − 𝐶𝑣𝑂# 
where CaO2 represents arterial oxygen content and CvO2 represents venous 
oxygen content. Therefore, cardiac output, the amount of blood pumped by the heart per 
minute, and the difference in oxygen content between arterial and venous blood determine 
oxygen consumption. Arterial oxygen content itself is defined as:  
  
	𝐶𝑎𝑂# = 1.34	(𝑚𝑙	𝑂#	𝑝𝑒𝑟	𝑔𝑟𝑎𝑚	𝐻𝑏) × 𝐻𝑏	(𝑔/𝐿) × 𝑆𝑎𝑂#	(%)		 
where 1.34 represents the oxygen-binding capacity of hemoglobin indicating that 1 
g of hemoglobin can bind 1.34 ml of oxygen, Hb represents hemoglobin concentration or 
the amount of hemoglobin in a volume of blood, the iron-containing protein within red 
blood cells that carries almost all the oxygen in the blood, and SaO2 represents arterial 
oxygen saturation, measured as the percentage of oxygen bound to hemoglobin. At sea 
level, the percentage of oxygen in the air is 20.9%, which corresponds to an arterial oxygen 
saturation between 96-99% in young healthy individuals (Pittman 2011).  
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Hemoglobin mass represents the absolute mass of circulating hemoglobin in the 
body. Because the transport of oxygen from the lungs to the exercising muscles is achieved 
through the binding of oxygen to hemoglobin, a greater hemoglobin mass results in an 
increase in oxygen-carrying capacity (Schmidt and Prommer 2010), and consequently a 
greater oxygen consumption, as shown by the strong relationship between hemoglobin 
mass and VO2max (Figure 1). Interventions that increase hemoglobin mass should, 
therefore, result in improved oxygen-carrying capacity and VO2max. 
 
 
Figure 1. Relationship between absolute maximal oxygen uptake (VO2max) and absolute 
total hemoglobin mass (tHb-mass) (Schmidt and Prommer 2010). Used with permission 
from Wolters Kluwer Heath, Inc. 
  
Effect of hypoxia on erythropoietin and hematological variables 
 
Exposure to low levels of oxygen, or hypoxia, stimulates the release of 
erythropoietin, the peptide hormone regulating the production of red blood cells, in order 
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to restore oxygen supply to the tissues. These exposures to low levels of oxygen can be 
achieved using hypobaric chambers or by breathing hypoxic gas mixtures under 
normobaric conditions (Ploszczyca et al. 2018). Following a rise in erythropoietin levels, 
it takes 5-6 days for a newly created reticulocyte to mature into a red blood cell and, 
consequently, observe an increased hemoglobin mass (Jelkmann 2011). Few studies 
(Eckardt et al. 1989, Knaupp et al. 1992, Klausen et al. 1996, Levine and Stray-Gundersen 
1997, Rodriguez et al. 2000, Gore et al. 2006, Schmidt and Prommer 2010, Turner et al. 
2017) have investigated the effects of short-term hypoxia on erythropoietin levels and 
hemoglobin mass. 
  
Single exposure to continuous hypoxia 
  
Few studies aimed to determine the hypoxic exposure duration needed to trigger an 
increase in erythropoietin levels. Single exposures to normobaric hypoxia at an oxygen 
level of 10.5% lasting 5 or 60 minutes were not sufficient to increase plasma erythropoietin 
levels in young healthy men (Knaupp et al. 1992). However, exposure to hypoxia for 120 
minutes yielded a 50% increase in plasma erythropoietin levels (Knaupp et al. 1992). 
Similarly, 2 continuous hours of normobaric hypoxia at ~13.55 % oxygen and 2 continuous 
hours of hypocapnic hypoxia at 10% oxygen increased erythropoietin levels by 22%  and 
28%, respectively, in young healthy men (Klausen et al. 1996, Turner et al. 2017). A single 
session of 90 minutes of hypoxia triggered a 55% rise in erythropoietin levels measured 3 
hours following the end of the hypoxic exposure in healthy men (Rodriguez et al. 2000). 
In addition, erythropoietin levels significantly increased by 33% following 90 minutes of 
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acute hypoxia exposure at a partial pressure of oxygen of 92 mmHg (Schmidt et al. 1991). 
In all cases, increases in erythropoietin levels were observed to peak approximately 2-3 
hours after termination of these continuous hypoxic exposures (Knaupp et al. 1992, 
Klausen et al. 1996, Rodriguez et al. 2000, Turner et al. 2017). None of these studies 
assessed red blood cell count or hemoglobin mass.  
 
Repeated exposures to continuous hypoxia  
 
Red blood cell count significantly increased following exposure to 90 minutes of 
hypoxia 3 times a week over 3 weeks in healthy men (Rodriguez et al. 2000). The increase 
in red blood count was significant after 2 weeks of exposure, and reached its highest value 
in the third week (Rodriguez et al. 2000). Although measures of erythropoietin levels were 
not performed, similar results were obtained following exposures to 3-5 hours of 
continuous hypoxia for 9 consecutive days, with an approximately 10% increase in red 
blood cell count in young healthy individuals (Rodriguez et al. 1999). On the other hand, 
while erythropoietin levels increased by 50% 3 hours following exposure to hypoxia, there 
was no increase in red blood cell volume or hemoglobin mass in collegiate runners and 
swimmers after 4 weeks of hypobaric hypoxia exposure (3 hours/day, 5 days/week) (Gore 
et al. 2006). Despite the elevated erythropoietin levels, the authors proposed that the dose 
of hypoxia, both oxygen levels and duration, was insufficient to stimulate erythropoiesis 
(Gore et al. 2006). Neocytolysis, the death of red blood cells which can occur after 
returning to normal barometric pressure, could explain the inability to trigger a sustained 
increase in red blood cell volume (Gore et al. 2006). 
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Intermittent hypoxia  
  
Intermittent hypoxia, defined as repeated short episodes of breathing hypoxic air 
interspersed with periods of breathing normoxic air, can also stimulate an increase in 
erythropoietin levels and red blood cell production (Knaupp et al. 1992, Burtscher et al. 
2004, Burtscher et al. 2009). Knaupp et al. (1992) demonstrated that 240 minutes of 
intermittent hypoxia, alternating between 2.5 minutes of breathing oxygen levels of 10.5% 
and 1.5 minutes of normoxic air, significantly increased erythropoietin levels by 52% in 
young healthy men. On the other hand, Julian et al. (2004) used a protocol of 5:5 minute 
of hypoxia-to-normoxia ratio for 70 minutes, 5 times a week, with oxygen levels 
progressively decreasing from 12 to 10% over 4 weeks in elite athletes but failed to see 
any elevations in erythropoietin levels or hemoglobin concentrations. However, several 
methodological limitations could explain this lack of increase in erythropoietin levels and 
hemoglobin concentration. First, erythropoietin levels, which return to baseline levels 6 
hours following a hypoxic exposure (Klausen et al. 1996), were measured at the same time 
each day (between 8 and 10 am) on the morning after participants were exposed to 
intermittent hypoxia, consequently preventing the detection of the rise in erythropoietin 
levels taken place in the first few hours following the hypoxic exposure. Second, the 
authors measured hemoglobin concentration, and not hemoglobin mass, which depends on 
plasma volume and is therefore greatly influenced by hydration status (Stray-Gundersen et 
al. 1992). Moreover, hemoglobin concentration correlates only to a modest extent with red 
blood cell mass (Schmidt and Prommer 2010). Hemoglobin mass is therefore a better 
marker of oxygen-carrying capacity (Schmidt and Prommer 2010). Third, elite endurance-
trained athletes possess 40-50 % higher hemoglobin mass compared with sedentary 
individuals (Heinicke et al. 2001, Schmidt and Prommer 2010). Therefore, sedentary 
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individuals may be more likely to experience an increase in red blood cell production 
stimulated by a hypoxia-induced elevation in erythropoietin levels.  
 
 Beneficial effects of intermittent hypoxia have been observed in untrained 
populations. Burtscher et al. (2004) used an intermittent protocol of 3 to 5 hypoxic bouts 
with oxygen levels progressively decreasing from 14 to 10% and exposure duration 
progressively increasing from 3 to 5 minute over a period of 3 weeks in elderly men with 
and without coronary artery disease. This intermittent hypoxia protocol significantly 
increased red blood cell count by 3.9%, indicating an improved oxygen-carrying capacity. 
This increase in red blood cell count correlated to an increased VO2peak in these 
individuals. A similar 3-week protocol of intermittent hypoxia at progressively declining 
oxygen levels of 15 to 12% increased total hemoglobin mass in patients at risk for or with 
mild, chronic obstructive pulmonary disease (Burtscher et al. 2009). Thus, exposure to 
intermittent hypoxia was reported to increase erythropoietin levels in young healthy 
individuals, and to increase red blood cell count and hemoglobin mass in clinical 
populations. It remains to be determined whether a single exposure to intermittent hypoxia 




The effect of a single exposure of intermittent hypoxia on both erythropoietin levels 
and hemoglobin mass remains equivocal in young, recreationally active healthy 
individuals. The aim of the present study was to determine whether a short 40-minute 
session of intermittent hypoxia, alternating 4 minutes of hypoxia at an arterial oxygen 
saturation of 90% with 4 minutes of normoxia, increases erythropoietin levels and 
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hemoglobin mass in young, recreationally active individuals. We hypothesized that 
intermittent hypoxia would increase erythropoietin levels and hemoglobin mass in young, 

























Maximal oxygen consumption (VO2max) represents the ability of the 
cardiovascular system to transport and use oxygen during maximal exercise. Oxygen 
transport from the lungs to the exercising muscles is achieved through the binding of 
oxygen to hemoglobin, a protein located in the red blood cell. The total mass of hemoglobin 
in the blood strongly correlates to VO2max (Schmidt and Prommer 2010). Therefore, 
interventions that increase hemoglobin mass should improve oxygen-carrying capacity 
and, consequently, VO2max. 
 
Exposure to low levels of oxygen, or hypoxia, stimulates the release of 
erythropoietin, the peptide hormone regulating the production of red blood cells. Following 
a rise in erythropoietin levels, it takes 5-6 days for a newly created reticulocyte to mature 
into a red blood cell, and to observe an increase in hemoglobin mass (Jelkmann 2011). 
Short exposures to continuous hypoxia lasting 90 min to 5.5 hours stimulate an increase in 
erythropoietin (Eckardt et al. 1989, Knaupp et al. 1992, Klausen et al. 1996, Rodriguez et 
al. 2000, Gore et al. 2006, Turner et al. 2017). No increase in erythropoietin levels was 
found after 5- and 60-min exposures to acute hypoxia at a fraction of inspired oxygen of 
0.105, however, a 50% increase in erythropoietin levels was seen following a 120-min 
hypoxic exposure (Knaupp et al. 1992). Others found similar increases in erythropoietin 
after 2 hours of hypoxia at a fraction of inspired oxygen of 0.135, 0.125 and 0.115 (Turner 
et al. 2017). While a single exposure of hypoxia stimulates an increase in erythropoietin 
levels, hemoglobin mass was not measured in these studies. Red blood cell volume 
increased as a result of repeated 90 min sessions of hypoxia, 3 days a week for 3 weeks 
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(Rodriguez et al. 1999, Rodriguez et al. 2000). However, 4 weeks of hypoxia for 3 hours a 
day, 5 days a week at an altitude of 4,000-5,000 m increased erythropoietin levels but not 
red blood cell production in well-trained athletes (Gore et al. 2006). 
 
Intermittent hypoxia consists of repeated short episodes of breathing hypoxic air 
interspersed with periods of breathing normoxic air. The proposed beneficial effect of 
intermittent hypoxia is that repeated stimulation of erythropoietin production would 
shorten the needed hypoxic exposure duration in order to increase oxygen carrying capacity 
(Rodriguez et al. 1999, Julian et al. 2004). Intermittent hypoxia lasting 240 minutes, 
alternating 2.5-minutes of hypoxia at 10.5% oxygen with 1.5-minutes of normoxia, 
significantly increased erythropoietin levels in young healthy men (Knaupp et al. 1992). 
Shorter repeated sessions of intermittent hypoxia consisting of hypoxic bouts of 3-5 min 
with 3 min normoxic periods at a progressively decreasing fraction of inspired oxygen from 
0.15 to 0.10, 5 times a week for 3 weeks, increased hemoglobin mass in men with and 
without coronary artery disease and individuals with mild chronic obstructive pulmonary 
disease (Burtscher et al. 2004, Burtscher et al. 2009). However, it remains unknown 
whether a single session of intermittent hypoxia increases hemoglobin mass. Thus, the 
objective of the present study was to evaluate if a short single session of intermittent 









Twenty young healthy individuals were recruited for the study, but 
carboxyhemoglobin levels could not be measured in one participant and was removed from 
the study leaving a total of nineteen participants (10 women) who completed the study. All 
participants provided informed written consent for participating in the study, which was 
approved by the Institutional Review Board of the University of Texas at Austin. 
Participants were excluded from the research project if they had a resting blood pressure 
above 140/90 mmHg, smoked cigarettes, were pregnant, had a history of cardiovascular 
disease, diabetes or lung disease, or were taking medication affecting the cardiovascular 
system.  
 
Study protocol  
  
Participants visited the Clinical Exercise Physiology Laboratory on 3 occasions 
over a period of 8 days. Nineteen individuals were randomly assigned to an intermittent 
hypoxia group (Hyp, n = 10, 5 women) or a placebo normoxic group (Norm, n = 9, 5 
women). During Visit 1 and 3, measures of hemoglobin mass, red blood cell volume, 
plasma volume, and total blood volume were performed. Visit 2 included measures of 
erythropoietin levels before and 2 hours following the completion of an intermittent 
hypoxia protocol or a placebo normoxic protocol. Visit 2 took place the day after Visit 1 





The intermittent hypoxia protocol consisted of five 4-minutes hypoxic cycles 
(arterial oxygen saturation of 90%) interspersed with 4-minutes normoxic cycles (Figure 
2) lasting a total of 40 minutes.  
 
 
Figure 2: Intermittent hypoxia protocol 
 
Participants inhaled hypoxic air through a mask connected to a 2-way non-
rebreathing valve (Hans Rudolph, Inc, USA), which itself was connected to a 5-liter non-
diffusing gas bag (Hans Rudolph, Inc, USA). The rebreathing bag was connected to a gas 
tank of compressed air. Air was made hypoxic by introducing nitrogen in the breathing 
circuit on the inspiratory port of the non-rebreathing valve. The flow of nitrogen was 
controlled to achieve an arterial oxygen saturation of 90%, as measured by pulse oximetry. 
Participants in the Norm group performed the same protocol, but nitrogen was not 
introduced in the breathing circuit. Gas exchange, hemodynamics, and arterial oxygen 
saturation were continuously measured during the intermittent hypoxia protocol and 






Hemoglobin mass was determined using the optimized carbon monoxide 
rebreathing technique (Lalande et al. 2012). Upon arrival to the laboratory, participants 
laid down on a treatment table, and all measures were performed in this position. A blood 
sample was first drawn via venipuncture from the antecubital fossa of the arm to measure 
carboxyhemoglobin, hematocrit, and hemoglobin levels (ABL 80 FLEX OSM, 
Radiometer, Copenhagen, Denmark). Participants then rebreathed a body size-related dose 
of carbon monoxide for a period of 2 minutes, while keeping a normal breathing rate. 
Carboxyhemoglobin levels were measured again 10 minutes following the start of the 
carbon monoxide rebreathing. Hemoglobin mass was calculated from the measured change 
in carboxyhemoglobin levels induced by the carbon monoxide rebreathing. Red blood cell 




An arterial waveform obtained by finger plethysmography from the middle finger 
of the left hand was continuously recorded (NOVA, Finapres Medical Systems, 
Amsterdam, Netherlands). Brachial arterial blood pressure, heart rate, stroke volume, 
cardiac output and total peripheral resistance were derived from the arterial waveform, a 
method that has been validated against invasive measures (Wesseling et al. 1993). Arterial 
oxygen saturation was also continuously monitored by pulse oximetry (NOVA, Finapres 
Medical Systems, Amsterdam, Netherlands) throughout the intermittent hypoxic protocol 
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and placebo normoxic protocol. All data was recorded in LabChart (Powerlab, 
ADInstruments Inc., CO, USA) for later analysis.  
 
Pulmonary gas exchange 
  
Breath-by-breath measures of pulmonary gas exchange such as volume of oxygen 
and carbon dioxide, respiratory rate, tidal volume and minute ventilation were determined 
from a pneumotachometer (Ultima Cardio2, MGC Diagnostics, MN, USA) throughout the 
intermittent hypoxic protocol and placebo normoxic protocol. The pneumotachometer was 
mounted between the mask and the non-rebreathing valve of the breathing circuit. 
 
Erythropoietin levels 
   
Upon arrival to the laboratory on Visit 2, a blood sample was first drawn via 
venipuncture from the antecubital fossa of the arm for later analysis of erythropoietin 
levels. Another blood draw was performed 2 hours following the completion of the 
intermittent hypoxia protocol or the placebo normoxic protocol. Following collection, 
blood was centrifuged and serum aliquoted and stored at -80°Cfor subsequent analyses. 
Erythropoietin levels were determined using an enzyme-linked immunosorbent assay 





Data and statistical analysis 
 
The last minute of each hypoxic cycle and normoxic was averaged in order to get 
the most stable values between all subjects.  A one-way repeated measured analysis of 
variance was used to evaluate whether each cycle of intermittent hypoxia or intermittent 
normoxia triggered the same physiological responses. There was no difference in 
pulmonary gas exchange, hemodynamics and arterial oxygen saturation across hypoxic 
cycles, therefore, average values were calculated for each variable. Similarly, there was no 
difference in any variables across normoxic cycles, and average values were calculated for 
each variable. A one-way repeated-measures analysis of variance was used to evaluate the 
effect of conditions (Hyp and Norm) on participants’ characteristics, pulmonary gas 
exchange, hemodynamics and arterial oxygen saturation. A two-way repeated measures 
analysis of variance was used to evaluate the effect of group (Hyp and Norm) and time (pre 
and post) on erythropoietin levels and hematological variables. When appropriate, post hoc 
analyses were performed using Tukey’s test. Significance was set at p ≤ 0.05. All values 













Age, weight, height, hemoglobin concentration, hematocrit levels, resting blood 
pressure, heart rate and physical activity levels were not different between groups (Table 
1). As anticipated, the Hyp group had a lower arterial oxygen saturation than the Norm 
group during the intervention (Table 2), which was equivalent to a lower fraction of 
inspired oxygen (Table 3). Exposure to intermittent hypoxia did not affect any 
hemodynamic or pulmonary gas exchange variables (Tables 2 and 3). 
 
Erythropoietin levels did not change following exposure to intermittent hypoxia 
(Figure 3). Plasma volume did not change following exposure to intermittent hypoxia 
(Hyp: 3730 ± 583 to 3592 ± 506, Norm: 3151 ± 508 to 3044 ± 481 ml, p = 0.48). 
Hemoglobin mass did not change after intermittent hypoxia or normoxia (Hyp: 789 ± 212 
to 760 ± 203, Norm: 683 ± 134 to 664 ± 137 grams, p = 0.68). Hemoglobin mass 
normalized to weight, red blood cell volume and blood volume did not change following 
















Table 1. Participants’ characteristics  




24 ± 2 
73.6 ± 13.3 
176 ± 11 
24 ± 6 
70.7 ± 11.4 
171 ± 10 
Hemoglobin (g/dl) 13.9 ± 1.6 14.3 ± 1.3 
Hematocrit (%) 42.8 ± 4.7 43.7 ± 3.9 
Systolic blood pressure (mmHg) 115 ± 11 120 ± 16 
Diastolic blood pressure (mmHg) 69 ± 8 72 ± 9 
Heart rate (bpm) 65 ± 8 64 ± 7  




























Table 2. Hemodynamics during intermittent hypoxia or normoxia 
  Hypoxia Normoxia  
Systolic blood pressure (mmHg) 126 ± 9 129 ± 16 
Diastolic blood pressure (mmHg) 73 ± 7 75 ± 11 
Heart rate (bpm) 74 ± 9 68 ± 8 
Mean arterial pressure (mmHg) 90 ± 6 93 ± 12 
Stroke volume (ml) 84 ± 20 82 ± 15 
Cardiac output (L/min) 6.2 ± 1.5 5.6 ± 1.2 
Total peripheral resistance (mmHg/L/min) 15.9 ± 4.2 17.7 ± 4.5 
Arterial oxygen saturation (%) 88.5 ± 1.3 * 98.5 ± 1.0 





























Table 3. Pulmonary gas exchange during intermittent hypoxia or normoxia 
 
  Hypoxia  Normoxia  
Fraction of inspired oxygen (%) 11.9 ± 0.8 * 20.9 ± 0.1 
End-tidal CO2 (mmHg) 34.9 ± 2.8 36.8 ± 3.4 
Ventilation (L/min) 7.9 ± 3.1 7.4 ± 2.3 
Tidal volume (ml) 684 ± 334 515 ± 142 
Respiratory rate (breaths/min) 14.0 ± 4.0 14.9 ± 3.0 























Figure 3. Erythropoietin levels before and 2 hours following the end of intermittent 












Figure 4. Hemoglobin mass (A), red blood cell volume (B) and blood volume (C) pre- 



































































The purpose of this study was to determine whether a single session of intermittent 
hypoxia increases erythropoietin levels and hemoglobin mass in young healthy individuals. 
Contrary to our hypothesis, a 40-minute session of intermittent hypoxia was not sufficient 
to elicit a rise in erythropoietin levels or oxygen-carrying capacity in young healthy 
individuals.  
 
Repeated exposures to intermittent hypoxia over several days and weeks leads to 
increased oxygen-carrying capacity (Rodriguez et al. 2000, Burtscher et al. 2004, Burtscher 
et al. 2009). Individuals with coronary artery disease showed an increase in red blood cells 
after 3 weeks of repeated sessions of intermittent hypoxia consisting of three to five 
hypoxic bouts at 14-10% oxygen, each lasting 3-5 min and separated by 3 min normoxic 
intervals (Burtscher et al. 2004). In addition, people at risk for or with mild chronic 
obstructive pulmonary disease performed a similar intermittent hypoxia protocol with a 
gradual decrease in oxygen from 15% to 12% and also demonstrated significant increases 
in hemoglobin mass after 3 weeks (Burtscher et al. 2009). Although erythropoietin levels 
were not measured in these studies, it is reasonable to assume that the hypoxia-induced 
increase in erythropoietin levels resulted in a greater red blood cell count. Although we 
used a similar intermittent hypoxia protocol to these previous studies (Burtscher et al. 2004, 
Julian et al. 2004, Burtscher et al. 2009), we did not see an increase in erythropoietin levels 
or hemoglobin mass in young healthy individuals. The timing of our erythropoietin 
measurements as well as the duration and severity of hypoxia possibly contributed to the 
observed lack of change in erythropoietin levels following exposure to intermittent 
hypoxia.    
 22 
Timing of erythropoietin response to hypoxia  
 
In the present study, erythropoietin levels did not change following a 40-minute 
exposure to intermittent hypoxia. Numerous studies reported that erythropoietin levels 
reach maximum levels 2 to 3 hours after the completion, or 4 to 6 hours following the 
onset, of a single session of hypoxia lasting between 90 minutes to 3 hours (Schmidt et al. 
1991, Knaupp et al. 1992, Klausen et al. 1996, Rodriguez et al. 2000, Gore et al. 2006, 
Turner et al. 2017). Similar to these previous studies, we performed measurements of 
erythropoietin levels 2 hours following the end of intermittent hypoxia. However, due to 
our shorter intermittent hypoxia protocol, these measurements occurred approximately 3 
hours following the onset of hypoxia, in comparison to previous studies observing peak 
levels between 4 and 6 hours after the onset of hypoxia. It is therefore possible that we did 
not detect the maximal increase in erythropoietin levels, and that erythropoietin levels were 
still rising following the exposure to intermittent hypoxia.  
 
It is also possible that the time at which erythropoietin levels peaks varies between 
exposures to continuous vs. intermittent hypoxia. During an intermittent hypoxia protocol 
of 240 minutes, consisting of 2.5 minutes of hypoxia at oxygen levels of 10.5% and 1.5 
minutes of nomoxia for a total hypoxic duration of 108 minutes, erythropoietin levels were 
significantly greater 6 hours after the onset of hypoxia. In comparison, peak levels of 
erythropoietin occurred 4 hours following exposure to 120 minutes of continuous hypoxia 
at oxygen levels of 10.5% (Knaupp et al. 1992). While the time spent under hypoxia was 
similar (108 vs. 120 minutes) and peak erythropoietin levels occurred 2 hours after 
completion of both protocols, peak levels from the onset of hypoxia occurred 2 hours apart 
(4 vs. 6 hours) between the continuous and intermittent protocols. Thus, an intermittent 
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protocol may delay the erythropoietin response to hypoxia, which possibly contributed to 
the observed lack of change in erythropoietin levels measured approximately 3 hours 
following our intermittent hypoxia protocol.  
 
There is a gradual rise in erythropoietin levels throughout the day, with levels 
peaking during the evening and night hours, increasing by 60% from the lowest levels 
occurring a few hours after waking (Wide et al. 1989, Klausen et al. 1993, Klausen et al. 
1996). All pre-intervention erythropoietin measurements occurred between 9 am and 12:30 
pm. Post-intervention erythropoietin measurements were scheduled 2 hours following the 
end of intermittent hypoxia, and thus occurred between 12:15 and 2:37 pm. Consequently, 
all blood samples were obtained during the time period with the lowest erythropoietin 
levels. Therefore, it is unlikely that a large diurnal variation masked an increase in 
erythropoietin levels.  Using each participant as its own control and performing all testing 
at the same time of day would have been beneficial in mitigating the effect of diurnal 
variation in erythropoietin levels. 
 
Duration and severity of hypoxia  
  
While it is possible that we missed the peak in erythropoietin levels, it is more likely 
that the short duration of our protocol better explains the lack of changes in erythropoietin 
levels. Previous findings suggest that a minimum hypoxic duration of 90 minutes is needed 
to elicit a significant increase in erythropoietin levels (Schmidt et al. 1991, Knaupp et al. 
1992, Klausen et al. 1996, Gore et al. 2006, Turner et al. 2017). Knaupp et al. (1992) 
measured erythropoietin levels in response to 5, 60, and 120 minutes of continuous hypoxia 
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at oxygen levels of 10.5%, and after 240 minutes of intermittent hypoxia. While 5 and 60 
minutes of continuous hypoxic was not sufficient to increase erythropoietin levels, 120 
minutes of continuous hypoxia and 240 minutes of intermittent hypoxia caused a 50% 
increase in erythropoietin levels. Therefore, the total duration of hypoxic exposure (20 
minutes) of our intermittent hypoxia protocol may have been too short to elicit changes in 
erythropoietin levels in young healthy individuals. Nevertheless, Burtscher et al. (2004, 
2009) performed similar total hypoxic exposures lasting between 9 and 25 minutes, and 
repeated exposures to these short hypoxic durations were effective in increasing red blood 
cell volume and hemoglobin mass.  
 
Our protocol targeted an arterial oxygen saturation of 90% which was equivalent 
to breathing 12% oxygen in young healthy individuals. However, many studies report 
significant erythropoietin level increases at lower arterial oxygen saturations, but not 
necessarily lower oxygen levels. While 2 hours of continuous hypoxia at oxygen levels of 
11.5% and 12.5%, equivalent to arterial oxygen saturations of 78% and 83%, increased 
erythropoietin levels, erythropoietin levels were not significantly elevated at an oxygen 
level of 13.5% which corresponded to an oxygen saturation of 87% (Turner et al. 2017). 
According to oxygen levels, these findings imply that the severity of our protocol was 
adequate to trigger an increase in erythropoietin levels, however, the resulting arterial 
oxygen saturations suggest that the 90% oxygen saturation used in this study may not have 




Individual variability in the erythropoietin response to hypoxia 
 
 Previous studies reported a large variability in the erythropoietin response to 
hypoxic exposure (Eckardt et al. 1989, Turner et al. 2017). A potential contributor to this 
individual variability is the use of fixed oxygen levels to induce hypoxia, which results in 
varying levels of hypoxemia as observed through different arterial oxygen saturations 
across participants. To attenuate the variability in individual responses to hypoxia, we 
customized the severity of hypoxia by titrating the flow of nitrogen into the breathing 
circuit to achieve a targeted arterial oxygen saturation with variable oxygen levels. 
Therefore, we believe that we were able to minimize the individual variability in the 
erythropoietin response to intermittent hypoxia.   
 
Pulmonary gas exchange and hemodynamics 
 
The intermittent hypoxia protocol used in the present study resulted in an average 
arterial oxygen saturation of 89%, which was equivalent to oxygen levels of 11.9%. This 
hypoxic exposure did not significantly affect any measures of pulmonary gas exchange or 
hemodynamics in young healthy individuals. Increases in heart rate were observed when 
arterial oxygen saturations dropped below 80% (Klausen et al. 1996, Faulhaber et al. 2015, 
Turner et al. 2017). While exposure to acute hypoxia may lead to increases in blood 
pressure through β-adrenergic stimulation (Prabhakar et al. 2005, Burtscher et al. 2009, 
Mateika et al. 2015), our data support previous literature stating that intermittent hypoxia 
is safe under moderate levels of hypoxia (ranging between 9-14%) and hypoxic durations 
of less than 2 hours. 
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In conclusion, a 40-minute session of intermittent hypoxia at an arterial oxygen 
saturation of 90% was not sufficient to elicit a rise in erythropoietin levels or hemoglobin 
mass in young healthy men and women. It is possible that we did not detect a rise in 
erythropoietin levels due to a premature measure of erythropoietin levels. Repeated 
sessions and/or a longer exposure to intermittent hypoxia may be necessary to trigger an 
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